Countervailing effects on atherogenesis and plaque stability: a paradoxical benefit of hypercoagulability?
- PMID: 19687352
- PMCID: PMC4443270
- DOI: 10.1161/CIRCULATIONAHA.109.889535
Countervailing effects on atherogenesis and plaque stability: a paradoxical benefit of hypercoagulability?
Figures
Comment on
-
Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.Circulation. 2009 Sep 1;120(9):774-84. doi: 10.1161/CIRCULATIONAHA.109.849539. Epub 2009 Aug 17. Circulation. 2009. PMID: 19687358
References
-
- Reitsma PH, Rosendaal FR. Past and future of genetic research in thrombosis. J Thromb Haemost. 2007;5 Suppl 1:264–269. - PubMed
-
- Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol. 2004;24:216–229. - PubMed
-
- van dK, Rosendaal FR, van der Bom JG, Doggen CJ. Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction. J Thromb Haemost. 2008;6:720–725. - PubMed
-
- Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118:2286–2297. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical